Davidson Kempner Capital Management’s Avalyn Pharma AVLN Stock Holding History
Bought
Maintained
Sold
Other funds holding AVLN
Davidson Kempner Capital Management's AVLN Position: Q3 2026 in Review
Davidson Kempner Capital Management sold out of Avalyn Pharma (AVLN) in Q3 2026, closing a stake of 23,000 shares — an estimated $757K sold.
Davidson Kempner Capital Management first reported a position in AVLN in Q2 2026 and held it in 1 quarter. The position peaked at $757K in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.
- Davidson Kempner Capital Management reported no remaining Avalyn Pharma position as of Q3 2026 after selling out during the quarter.
- Davidson Kempner Capital Management sold 23,000 Avalyn Pharma shares in Q3 2026, an estimated $757K.
- Davidson Kempner Capital Management first reported a position in Avalyn Pharma in Q2 2026 and held it in 1 quarter.
- Davidson Kempner Capital Management's Avalyn Pharma position peaked at $757K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.
Based on Davidson Kempner Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.